Jade Therapeutics
Biodegradable hyaluronic acid polymer film delivering antibiotics continuously to the corneal surface
- Sector
- Medtech
- Headquarters
- SALT LAKE CITY, X1
- Founded
- 2011
- Latest Form D
- $800K offered, Dec 2014
- Total capital
- $1.5M
- Federal grants
- $725K
- 1 award · 2014
- Rank in peer group#89 of 445
- Private capital raised
- $800K
- 2 Form D · last Dec 2014
- 142 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 4 pending · first 2017
- Rank in peer group#109 of 445
Capital timeline
Latest events
- Offering registeredForm D · SEC · 2nd filing$800K
- Federal grantNSF · Phase II · SBIR Phase II: Biodegradable Polymer Film for Sustained Delivery of Antibiotics to the Surface of the Eye$725K
- Offering registeredForm D · SEC · 1st filing$600K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 445 peers
Line = medianMedtech · Device
- Federal grants#89 · top 20%
- Granted patents#109 · top 24%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Barbara WirostkoResearcherExecutive Officer, DirectorLinked by 1 patent · $725K in grants as PI
- Arthur KlausnerExecutive Officer, DirectorNamed in SEC Form D filings
- Dinesh PatelDirectorNamed in SEC Form D filings
- Mary Jane RafiiExecutive Officer, DirectorNamed in SEC Form D filings
- Randall OlsonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 5- GrantedOcular Composition And MethodUSPTOUS 9,782,345
- PendingOcular Drug Delivery SystemUSPTOApplication 14872864
- PendingOcular Drug Delivery SystemUSPTOApplication 13835729
Show all 5 patent records
- Ocular Composition And MethodOct 10, 2017 · US 9,782,345Granted
- Ocular Drug Delivery SystemJan 21, 2016 · Application 14872864Pending
- Ocular Drug Delivery SystemApr 17, 2014 · Application 13835729Pending
- Ocular Composition And MethodApplication 14517041Pending
- Ocular Drug Delivery SystemApplication PCTUS2013036807Pending
Related companies, and why
- ParaNano Wound Care, LLCSimilar federal contract value in Medtech · null in contracts
- FireHUD, Inc.Similar federal contract value in Medtech · null in contracts
- Taproot Medical TechnologiesSimilar federal contract value in Medtech · null in contracts
- OSTEOVANTAGE, INCSimilar federal contract value in Medtech · null in contracts
- WISEWEAR CORPORATIONSimilar federal contract value in Medtech · null in contracts
- Trace Sensing Technologies Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .